These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7956947)

  • 101. Molecular analysis of transforming growth factor beta in giant cell tumor of bone.
    Butler MG; Dahir GA; Schwartz HS
    Cancer Genet Cytogenet; 1993 Apr; 66(2):108-12. PubMed ID: 8500096
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Bioenergetics of rat prostate cancer cell migration.
    Kouvroukoglou S; Lakkis CL; Wallace JD; Zygourakis K; Epner DE
    Prostate; 1998 Feb; 34(2):137-44. PubMed ID: 9465945
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Transgenic models for the study of prostate cancer.
    Thompson TC; Truong LD; Timme TL; Kadmon D; McCune BK; Flanders KC; Scardino PT; Park SH
    Cancer; 1993 Feb; 71(3 Suppl):1165-71. PubMed ID: 8428340
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Immunochemical study of transforming growth factor-beta in the kidney of the rat and chicken.
    Díaz-Ruiz C; Montaner B; Pérez-Tomás R
    Histochem Cell Biol; 1996 Jun; 105(6):475-8. PubMed ID: 8791107
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Comparison of hock- and footpad-injection as a prostate adenocarcinoma model in rats.
    Richter H; Karol A; Nuss K; Lenisa A; Bruellmann E; Maudens SS; Hoffmann H; von Rechenberg B; Kircher PR
    BMC Vet Res; 2018 Nov; 14(1):327. PubMed ID: 30400793
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Detection by DNA fingerprinting of somatic changes during the establishment of a new prostate cell line.
    van Helden PD; Wiid IJ; Hoal-van Helden EG; Bey E; Cohen R
    Br J Cancer; 1994 Aug; 70(2):195-8. PubMed ID: 8054265
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor.
    Zhao D; Constantinescu A; Hahn EW; Mason RP
    Radiat Res; 2001 Nov; 156(5 Pt 1):510-20. PubMed ID: 11604064
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions.
    Dow JK; deVere White RW
    Urology; 2000 Jun; 55(6):800-6. PubMed ID: 10840080
    [No Abstract]   [Full Text] [Related]  

  • 109. TGF-beta 3 expression correlates with epithelial cell death in normal, hyperplastic and malignant prostate.
    Djonov V; Andres A; Altermatt H; Merz V
    Int J Oncol; 1997 Dec; 11(6):1185-90. PubMed ID: 21528320
    [TBL] [Abstract][Full Text] [Related]  

  • 110. High energy shock waves do not affect either primary tumor growth or metastasis of prostate carcinoma, R3327-MatLyLu.
    Geldof AA; De Voogt HJ; Rao BR
    Urol Res; 1989; 17(1):9-12. PubMed ID: 2922893
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Prostate cancer: TGF-β signalling regulator PMEPA1 halts metastases to bone.
    Stone L
    Nat Rev Urol; 2015 Jul; 12(7):362. PubMed ID: 26057060
    [No Abstract]   [Full Text] [Related]  

  • 112. Changes in tumor characteristics during progression of the R3327 HI experimental prostatic carcinoma.
    Mobbs BG; Johnson IE
    Prostate; 1990; 16(2):127-36. PubMed ID: 1690881
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.
    Zechmann CM; Woenne EC; Brix G; Radzwill N; Ilg M; Bachert P; Peschke P; Kirsch S; Kauczor HU; Delorme S; Semmler W; Kiessling F
    Neoplasia; 2007 Jan; 9(1):57-67. PubMed ID: 17325744
    [TBL] [Abstract][Full Text] [Related]  

  • 114. TGF-β mediated DNA methylation in prostate cancer.
    Lee C; Zhang Q; Zi X; Dash A; Soares MB; Rahmatpanah F; Jia Z; McClelland M; Mercola D
    Transl Androl Urol; 2012 Jun; 1(2):78-88. PubMed ID: 25133096
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Decreased protein expression of candidate tumor suppressors TET3 and EPB41L3 in prostate cancers.
    Mo HY; Son HJ; Choi EJ; Yoo NJ
    Pathol Res Pract; 2020 Feb; 216(2):152815. PubMed ID: 31937425
    [No Abstract]   [Full Text] [Related]  

  • 116. Rat prostate tumors induce DNA synthesis in remote organs.
    Halin Bergström S; Lundholm M; Nordstrand A; Bergh A
    Sci Rep; 2022 May; 12(1):7908. PubMed ID: 35551231
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A rapid colorimetric bioassay for transforming growth factor beta (TGF-beta) using a microwell plate reader.
    Absher M; Baldor L; Kelley J
    J Immunol Methods; 1991 Apr; 138(2):301-3. PubMed ID: 2033282
    [No Abstract]   [Full Text] [Related]  

  • 118. Correction: Cofilin Drives Cell-Invasive and Metastatic Responses to TGF-β in Prostate Cancer.
    Cancer Res; 2018 Sep; 78(17):5180. PubMed ID: 30181304
    [No Abstract]   [Full Text] [Related]  

  • 119. A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer.
    Crowley F; Sterpi M; Buckley C; Margetich L; Handa S; Dovey Z
    Res Rep Urol; 2021; 13():457-472. PubMed ID: 34235102
    [TBL] [Abstract][Full Text] [Related]  

  • 120. SMAD3 promotes ELK3 expression following transforming growth factor β-mediated stimulation of MDA-MB231 cells.
    Park JH; Park KS
    Oncol Lett; 2020 Apr; 19(4):2749-2754. PubMed ID: 32218827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.